Calliditas Therapeutics AB Net Foreign Exchange Loss
Calliditas Therapeutics AB reported Net Foreign Exchange Loss of SEK 596.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-24.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:NetForeignExchangeLoss · last filed 2024-04-24
| Period end | Net Foreign Exchange Loss 12 month |
|---|---|
| 2023-12-31 | 596.00K SEK 20-F · filed 2024-04-24 |
| 2022-12-31 | 7.13M SEK 20-F · filed 2024-04-24 |
| 2021-12-31 | 1.81M SEK 20-F · filed 2024-04-24 |
| 2020-12-31 | 0.00 SEK 6-K · filed 2021-04-27 |
| 2019-12-31 | 4.46M SEK 20-F · filed 2022-04-27 |
| 2018-12-31 | 2.09M SEK 20-F/A · filed 2022-01-14 |